A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
Ethoxzolamide has been studied across 11 research domains including 👁️ Vision & Eye, ❤️ Cardiovascular, 🔬 Oncology, 🧠 Focus & Attention, 🧠 Neuroprotection. The primary research focus is 👁️ Vision & Eye with 22% of studies addressing this area.
This evidence profile for Ethoxzolamide is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.